Cargando…
PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
OBJECTIVE: The BRAF inhibitor, vemurafenib, has been widely used in the treatment of patients with melanoma-bearing BRAF(V600E) mutations. While the initial response to vemurafenib is usually excellent, the majority of patients eventually develop resistance and metastatic disease. However, the under...
Autores principales: | Shen, Junling, Yang, Jilong, Sang, Lei, Sun, Rui, Bai, Weiyu, Wang, Chao, Sun, Yan, Sun, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425182/ https://www.ncbi.nlm.nih.gov/pubmed/34570440 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0294 |
Ejemplares similares
-
Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells
por: Genna, Alessandro, et al.
Publicado: (2018) -
The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma
por: Iizuka, Shinji, et al.
Publicado: (2016) -
IKKε phosphorylates kindlin-2 to induce invadopodia formation and promote colorectal cancer metastasis
por: Liu, Ge, et al.
Publicado: (2020) -
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers
por: Karamanou, Konstantina, et al.
Publicado: (2021) -
Dense collagen kindles invadopodia formation
por: Short, Ben
Publicado: (2015)